NCT04623931View on ClinicalTrials.gov

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Anaplastic Astrocytoma, IDH-WildtypeAnaplastic OligoastrocytomaAnaplastic OligodendrogliomaDiffuse Astrocytoma, IDH-WildtypeGlioblastomaOligoastrocytomaOligodendrogliomaWHO Grade II GliomaWHO Grade III Glioma
Interventions
OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Radiation Therapy

Undergo radiation therapy

DRUG

Temozolomide

Given PO

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER